Status:
WITHDRAWN
Long-term Surival of GIST Patients ≥ 10 Years on Imatinib
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Conditions:
GIST
Eligibility:
All Genders
28+ years
Brief Summary
This is a cross-sectional cohort study of metastatic GastroIntestinal Stromal Tumor (GIST) patients on imatinib for ≥ 10 years included in EORTC trial 62005-STBSG entitled "Phase 3 randomized, intergr...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients included in the EORTC 62005 trial: Adult patients with metastasized GIST
- Patients who have been treated with imatinib for ten years or longer
- For the identified patients who are still alive:
- Able to read and answer questionnaires
- Able to provide written informed consent
Exclusion
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04097093
Start Date
June 1 2020
End Date
June 1 2021
Last Update
September 2 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.